1. CP-065 Dose reduction and discontinuation of chemotherapy in cancer patients experiencing drug-drug interactions. (14th February 2016) Authors: Buchner, P; Büchler, W; Wagenbauer, E; Haider, D Journal: European journal of hospital pharmacy Issue: Volume 23(2016)Supplement 1 Page Start: A29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P-168Multiple dose pharmacokinetics of erlotinib when combined with gastric acid reducing agents: A comparison with a physiologically based pharmacokinetic model. (20th June 2018) Authors: Hrgovcic, A Sahmanovic; Gruber, A; Dittrich, C; Kitzmueller, M; Buchner, P; Baroian, N Kirchbaumer; Czejka, M Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗